召集会议
发表于 2025-3-21 16:15:02
书目名称Radiopharmaceutical Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0820888<br><br> <br><br>书目名称Radiopharmaceutical Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0820888<br><br> <br><br>
Volatile-Oils
发表于 2025-3-21 22:31:39
http://reply.papertrans.cn/83/8209/820888/820888_2.png
RACE
发表于 2025-3-22 03:50:12
978-3-031-39772-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
说笑
发表于 2025-3-22 04:52:31
Lisa Bodei,Jason S. Lewis,Brian M. ZeglisFirst book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
长矛
发表于 2025-3-22 09:07:33
The Production of Therapeutic Radionuclidesh the decay of long-lived radionuclides such as .U, .Th, and .U, upon which chemically distinct daughters can be separated for incorporation into radiopharmaceuticals. The rate of the production of a given radionuclide depends on the cross section of the nuclear reaction on the target material, the
MOAT
发表于 2025-3-22 13:41:48
http://reply.papertrans.cn/83/8209/820888/820888_6.png
出血
发表于 2025-3-22 17:46:55
http://reply.papertrans.cn/83/8209/820888/820888_7.png
热情赞扬
发表于 2025-3-23 00:06:59
http://reply.papertrans.cn/83/8209/820888/820888_8.png
Flatus
发表于 2025-3-23 05:23:38
Case Study #3: Antibody Fragments in Radiopharmaceutical Therapylity, unfavorable tissue distribution, and reduced binding affinity of radiolabeled antibody fragments have inhibited their widespread application in radiopharmaceutical therapy. In response, a great deal of effort has been dedicated to optimize the pharmacokinetics of antibody fragments (especially
分解
发表于 2025-3-23 06:38:13
http://reply.papertrans.cn/83/8209/820888/820888_10.png